Tighe Reardon - Net Worth and Insider Trading
Tighe Reardon Net Worth
The estimated net worth of Tighe Reardon is at least $337 Million dollars as of 2024-11-13. Tighe Reardon is the Acting CFO of Janux Therapeutics Inc and owns about 4,148,680 shares of Janux Therapeutics Inc (JANX) stock worth over $220 Million. Tighe Reardon is also the Acting CFO of Synthorx Inc and owns about 1,725,774 shares of Synthorx Inc (THOR) stock worth over $117 Million. Details can be seen in Tighe Reardon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tighe Reardon has not made any transactions after 2024-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tighe Reardon
Tighe Reardon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tighe Reardon owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Tighe Reardon’s form 4 insider trades.
Insider Ownership Summary of Tighe Reardon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-06-03 | 10 percent owner & Acting Chief Financial Officer |
Tighe Reardon Latest Holdings Summary
Tighe Reardon currently owns a total of 2 stocks. Among these stocks, Tighe Reardon owns 4,148,680 shares of Janux Therapeutics Inc (JANX) as of June 3, 2024, with a value of $220 Million and a weighting of 65.17%. Tighe Reardon also owns 1,725,774 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $117 Million and a weighting of 34.83%.
Latest Holdings of Tighe Reardon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-06-03 | 4,148,680 | 52.91 | 219,506,659 |
| THOR | Synthorx Inc | 2018-12-11 | 1,725,774 | 67.99 | 117,335,374 |
Holding Weightings of Tighe Reardon
Tighe Reardon Form 4 Trading Tracker
According to the SEC Form 4 filings, Tighe Reardon has made a total of 2 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 822,721 shares on June 3, 2024, which brought Tighe Reardon around $45 Million.
According to the SEC Form 4 filings, Tighe Reardon has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 545,455 shares on December 11, 2018, which cost Tighe Reardon around $6 Million.
Insider Trading History of Tighe Reardon
- 1
Tighe Reardon Trading Performance
GuruFocus tracks the stock performance after each of Tighe Reardon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tighe Reardon is 17.63%. GuruFocus also compares Tighe Reardon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tighe Reardon within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tighe Reardon's insider trading performs compared to the benchmark.
Performance of Tighe Reardon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.78 | | | | | |
| Relative Return to S&P 500(%) | 16.2 | | | | | |
Tighe Reardon Ownership Network
Ownership Network List of Tighe Reardon
Ownership Network Relation of Tighe Reardon
Tighe Reardon Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Tighe Reardon is the 10 percent owner & Acting Chief Financial Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & Chief Executive Officer David Alan Campbell , director & 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Avalon Ventures Xi, L.p. .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Tighe Reardon made 2 insider transaction in Janux Therapeutics Inc (JANX) with a net purchase of 27,133. Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 653,961 shares made by Jay Lichter , and a net purchase of 1,695,008 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 2,782,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,582,995 shares. During the past 18 months, 6,605,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,361,146 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
Tighe Reardon Mailing Address
Above is the net worth, insider trading, and ownership report for Tighe Reardon. You might contact Tighe Reardon via mailing address: C/o Synthorx, Inc., 11099 North Torrey Pines Road, Suite 190, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
